Amphastar Pharmaceuticals (AMPH) EPS (Basic) Growth (3y) (2016 - 2026)
Amphastar Pharmaceuticals (AMPH) EPS (Basic) Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 934.42 Mn | 644.30 Mn | 93.47 Mn | 8.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.40% |
| Mar 31, 2026 | -36.71% |
| Dec 31, 2025 | 13.31% |
| Sep 30, 2025 | 4.42% |
| Jun 30, 2025 | 22.43% |
| Mar 31, 2025 | 0.79% |
| Dec 31, 2024 | 23.32% |
| Sep 30, 2024 | 8.85% |
| Jun 30, 2024 | 62.56% |
| Mar 31, 2024 | 121.67% |
| Dec 31, 2023 | -190.20% |
| Sep 30, 2023 | 116.12% |
| Jun 30, 2023 | 170.81% |
| Mar 31, 2023 | 94.48% |
| Dec 31, 2022 | 23.11% |
| Sep 30, 2022 | 150.63% |
| Jun 30, 2022 | -28.76% |
| Mar 31, 2022 | 136.63% |
| Dec 31, 2021 | 124.31% |
| Sep 30, 2021 | 164.23% |